Stockscreener 앱 받기
1.725
7.26%
-0.135
시간 외 거래:
1.80
0.075
+4.35%
전일 마감가:
$1.86
열려 있는:
$1.88
하루 거래량:
29,085
Relative Volume:
0.39
시가총액:
$8.38M
수익:
-
순이익/손실:
$-39.62M
주가수익비율:
-0.00104
EPS:
-1654.3275
순현금흐름:
$-17.96M
1주 성능:
-13.97%
1개월 성능:
-63.06%
6개월 성능:
-96.91%
1년 성능:
-99.86%
1일 변동 폭
$1.6912
$1.9334
1주일 범위
$1.6912
$2.1896
52주 변동 폭
$1.6912
$1,216.80
Cdt Equity Inc Stock (CDT) Company Profile
명칭
Cdt Equity Inc
전화
(646) 491 9132
주소
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
1.725 | 9.04M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
436.95 | 114.32B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
698.25 | 74.74B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
799.32 | 51.13B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
286.98 | 39.18B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
145.66 | 31.78B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cdt Equity Inc 주식(CDT)의 최신 뉴스
CDT Equity Flags Delay in Quarterly Filing - TipRanks
CDT Equity Modifies Financing Agreements to Boost Liquidity - TipRanks
CDT Equity (NASDAQ: CDT) notifies SEC of delayed Q1 2026 10-Q; plans filing - Stock Titan
Cdt Equity Inc enters amendment no. 2 to equity line of credit facility on May 15, 2026SEC filing - marketscreener.com
CDT Equity Inc. (NASDAQ: CDT) tweaks equity line and note proceeds - Stock Titan
Corvus updates CDT Equity (CDT) ownership to about a 5.4% stake - Stock Titan
CEO-linked entities of CDT Equity (CDT) add shares, exercise warrants - Stock Titan
Number of shareholders of CDT Equity Inc. – NASDAQ:CDT - TradingView
CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection Stage - Yahoo Finance
CDT Stock Price, Quote & Chart | CDT EQUITY INC (NASDAQ:CDT) - ChartMill
CDT Equity Inc shares plunge 7.96% as Q1 2026 shows zero revenue and massive loss.Direct Listing - newser.com
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market - The Manila Times
A patent filed in under 3 weeks puts CDT's Sarborg stake in focus - Stock Titan
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - AI Magazine
After 181-subject safety studies, CDT seeks partner for infertility drug - Stock Titan
CDT Equity Inc. Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - marketscreener.com
[EFFECT] CDT Equity Inc. SEC Filing - Stock Titan
5.35M CDT Equity (NASDAQ: CDT) shares registered for resale by selling holders - Stock Titan
CDT Equity (CDT) director discloses 233,585 Common Stock shares on Form 3 - Stock Titan
CDTTW (CDT Warrant) leadership outlines long-term growth priorities as latest quarterly earnings figures remain undisclosed.Recovery Report - newser.com
CDT Equity Announces Board Changes and New Chairperson - The Globe and Mail
CDT Equity announces reverse stock split - MSN
Board reshuffle at CDT Equity (NASDAQ: CDT) adds Ulrik Olsen, new chairs - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Conduit to change name to CDT Equity - MSN
Stock List: Research Stocks from Around the World - GuruFocus
Working capital per share of CDT Equity Inc. – FWB:ZK7 - TradingView
EBITDA per share of CDT Equity Inc. – FWB:ZK7 - TradingView
CDT Equityfiles for offering of up to 5.35 million shares of common stockSEC filing - marketscreener.com
CDT Equity (NASDAQ: CDT) registers 5.35M shares; ELOC and Sarborg issuances - Stock Titan
Equity Inc (CDT) Stock: Is It Reasonably Valued (Dips) 2026-04-20Elite Trading Signals - Xã Thanh Hà
CDT Notes Sarborg Publication of PRISM Framework Expanding AI - 富途牛牛
Prospect Capital Securities Ltd Net Worth (2026) - GuruFocus
Prospect Finance Ltd Net Worth (2026) - GuruFocus
Mark Andrew Taylor Net Worth (2026) - GuruFocus
Keep an eye on the top gainers and losers in Thursday's session. - ChartMill
AstraZeneca (AZN) Advances Portfolio with Strategic Update - GuruFocus
CDT Equity expands multi-pathway value creation strategy across pharma, IP - TipRanks
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery - The Manila Times
Tiny Nasdaq biotech links AstraZeneca assets with AI drug hunting - Stock Titan
CDT Equity Inc. 2025 Annual Report: Nasdaq Listing, Reverse Stock Splits, and Financial Highlights (CDT, CDTTW) - Minichart
CDT Equity Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
AI-focused CDT Equity (Nasdaq: CDT) warns of going concern risk - Stock Titan
What's Going On With CDT Equity Shares On Monday? - Sahm
CDT Equity Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Which stocks are experiencing notable movement on Friday? - ChartMill
Cdt Equity Inc (CDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.71%
자본화:
|
볼륨(24시간):